# A Bioequivalence Study of Losartan Potassium Tablets (Containing Losartan Potassium 100 mg) in Normal, Healthy, Adults Under Fasting Conditions

> **NCT03459911** · PHASE1 · COMPLETED · sponsor: **Pharmtechnology LLC** · enrollment: 66 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Cozaar 100mg Tablet
- **DRUG:** Losartan potassium 100mg

## Key facts

- **NCT ID:** NCT03459911
- **Lead sponsor:** Pharmtechnology LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-16
- **Primary completion:** 2018-03-11
- **Final completion:** 2018-03-16
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2018-11-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03459911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03459911, "A Bioequivalence Study of Losartan Potassium Tablets (Containing Losartan Potassium 100 mg) in Normal, Healthy, Adults Under Fasting Conditions". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03459911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*